<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114110</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Infantile Hemangiomas Treated by Sequential Application of Pulsed Dye Laser and Nd:YAG Laser Radiation: A Retrospective Study</dc:title>
<dc:description xml:lang="en">Background and objectives: Infantile hemangiomas are the most common benign tumor in children. They have 3 phases of development: a proliferative phase, an involuting phase, and involution. Although active treatment is often not required, it is necessary in some cases. Of the possible treatments for hemangiomas, lasers have been shown to be effective in all phases of development. We report our experience with dual-wavelength sequential pulses from a pulsed dye laser and an Nd:YAG laser. Material and methods: This was a retrospective, descriptive study of patients with infantile hemangioma in different phases of development treated with pulsed dye laser pulses followed by Nd:YAG laser pulses. Four dermatologists assessed the effectiveness of treatment on a scale of 10 to 0. Adverse effects and incidents related to treatment were recorded. The median and interquartile range were calculated as descriptive statistics. Pretreatment and posttreatment comparisons were performed using the Wilcoxon test. Results: Twenty-two patients with hemangiomas in different phases of development were included. A statistically significant improvement was obtained both for the entire group and for different subgroups. Posttreatment events were reported in 4 patients, and included edema and ulceration, skin atrophy, and hyperpigmentation. Conclusions: We believe that treatment with dual-wavelength light from a pulsed dye laser and a Nd:YAG laser is a viable treatment option for infantile hemangiomas when first-line therapies are ineffective or contraindicated (AU)</dc:description>
<dc:creator>Alonso-Castro, L</dc:creator>
<dc:creator>Jaén Olasolo, P</dc:creator>
<dc:creator>Alcántara-González, J</dc:creator>
<dc:creator>Truchuelo-Díez, M. T</dc:creator>
<dc:creator>Pérez-García, B</dc:creator>
<dc:creator>Boixeda, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Los hemangiomas infantiles son los tumores benignos más frecuentes en la infancia, presentando una fase proliferativa, una fase de involución y una fase residual. En muchas ocasiones no precisan de un tratamiento activo. No obstante, en algunos pacientes se impone la necesidad de un tratamiento. Entre las posibilidades terapéuticas ha demostrado utilidad, durante todas las fases evolutivas de la lesión, el tratamiento con láser. Comunicamos nuestra experiencia con el láser dual secuencial de colorante pulsado (LCP) y Nd:YAG. Material y métodos: Se efectuó un estudio retrospectivo y descriptivo de los pacientes con hemangiomas infantiles en diversas fases evolutivas tratados con el láser dual de LCP y Nd:YAG. Cuatro dermatólogos valoraron el grado de efectividad en una escala del 10 al 0. Se recogieron los efectos adversos e incidencias relativas al tratamiento. En el análisis se utilizó para los valores descriptivos la mediana y el rango intercuartílico y la prueba de Wilcoxon para la comparación pre y postratamiento. Resultados: Se recogieron 22 pacientes con hemangiomas en distintos estadios evolutivos, obteniéndose una mejoría estadísticamente significativa tanto en el conjunto de todos los pacientes como en los distintos subgrupos. Cuatro pacientes presentaron incidencias postratamiento: edema y ulceración, atrofia cutánea e hiperpigmentación. Conclusiones: Consideramos que el láser dual de LCP y Nd:YAG puede ser una alternativa para el tratamiento de hemangiomas infantiles cuando las terapias consideradas de primera línea se muestran ineficaces o están contraindicadas (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;104(6): 504-511, jul. 2013. tab, ilus</dc:source>
<dc:identifier>ibc-114110</dc:identifier>
<dc:title xml:lang="es">Hemangiomas infantiles tratados con aplicación secuencial de láser de colorante pulsado y Nd:YAG: estudio retrospectivo</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d52861^s22020</dc:subject>
<dc:subject>^d52861^s22074</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d32016</dc:subject>
<dc:subject>^d52861^s22045</dc:subject>
<dc:subject>^d11865^s22073</dc:subject>
<dc:subject>^d4555^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d6542^s22067</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d1290^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d6542^s22016</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d52874^s22073</dc:subject>
<dc:subject>^d30694^s22012</dc:subject>
<dc:subject>^d52861^s22039</dc:subject>
<dc:subject>^d14061^s22067</dc:subject>
<dc:type>article</dc:type>
<dc:date>201307</dc:date>
</metadata>
</record>
</ibecs-document>
